Novo Nordisk A/S (CPH:NOVO.B)
Denmark · Delayed Price · Currency is DKK 306.15
+1.05 (0.34%)
Aug 10, 2026, 4:59 PM CET
Novo Nordisk Income Statement
Financials in millions DKK. Fiscal year is January - December.
Millions DKK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 329,431 | 309,064 | 290,403 | 232,261 | 176,954 | 140,800 | |
Revenue Growth | 5.61% | 6.43% | 25.03% | 31.25% | 25.68% | 10.91% |
Cost of Revenue | 59,339 | 54,377 | 43,560 | 35,319 | 28,424 | 23,658 |
Gross Profit | 270,092 | 254,687 | 246,843 | 196,942 | 148,530 | 117,142 |
Selling, General & Admin | 62,427 | 67,865 | 67,368 | 61,594 | 50,683 | 41,058 |
Research & Development | 45,904 | 46,159 | 40,072 | 31,075 | 23,263 | 17,199 |
Other Operating Expenses | 376 | 45 | 502 | -425 | -1,034 | -332 |
Operating Expenses | 108,707 | 114,069 | 107,942 | 92,244 | 72,912 | 57,925 |
Operating Income | 161,385 | 140,618 | 138,901 | 104,698 | 75,618 | 59,217 |
Interest Expense | -103 | -4,207 | -1,640 | -542 | -378 | -289 |
Interest & Investment Income | 935 | 1,269 | 1,838 | 1,069 | 239 | 231 |
Earnings From Equity Investments | -17 | -17 | -17 | 81 | -189 | -24 |
Currency Exchange Gain (Loss) | 6,007 | 6,007 | -1,023 | 1,652 | -4,651 | 344 |
Other Non Operating Income (Expenses) | -241 | -241 | -289 | -197 | -181 | -122 |
EBT Excluding Unusual Items | 167,966 | 143,429 | 137,770 | 106,761 | 70,458 | 59,357 |
Merger & Restructuring Charges | -9,366 | -9,366 | - | - | - | - |
Gain (Loss) on Sale of Investments | 71 | 71 | -17 | 37 | -587 | 296 |
Asset Writedown | -9,922 | -3,594 | -10,562 | -2,124 | -809 | -573 |
Pretax Income | 148,749 | 130,540 | 127,191 | 104,674 | 69,062 | 59,080 |
Income Tax Expense | 32,306 | 28,106 | 26,203 | 20,991 | 13,537 | 11,323 |
Net Income | 116,443 | 102,434 | 100,988 | 83,683 | 55,525 | 47,757 |
Net Income to Common | 116,443 | 102,434 | 100,988 | 83,683 | 55,525 | 47,757 |
Net Income Growth | 4.84% | 1.43% | 20.68% | 50.71% | 16.27% | 13.33% |
Shares Outstanding (Basic) | 4,441 | 4,443 | 4,454 | 4,483 | 4,531 | 4,593 |
Shares Outstanding (Diluted) | 4,445 | 4,448 | 4,463 | 4,495 | 4,545 | 4,606 |
Shares Change | -0.14% | -0.34% | -0.71% | -1.10% | -1.34% | -1.58% |
EPS (Basic) | 26.22 | 23.06 | 22.67 | 18.67 | 12.26 | 10.40 |
EPS (Diluted) | 26.20 | 23.03 | 22.63 | 18.62 | 12.22 | 10.37 |
EPS Growth | 4.98% | 1.77% | 21.54% | 52.37% | 17.84% | 15.16% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 75,838 | 58,962 | 73,804 | 83,102 | 66,741 | 48,665 |
Free Cash Flow Per Share | 17.06 | 13.26 | 16.54 | 18.49 | 14.69 | 10.56 |
Dividend Per Share | 11.700 | 11.700 | 11.400 | 9.400 | 6.200 | 5.200 |
Dividend Growth | 0.43% | 2.63% | 21.28% | 51.61% | 19.23% | 14.29% |
Gross Margin | 81.99% | 82.41% | 85.00% | 84.79% | 83.94% | 83.20% |
Operating Margin | 48.99% | 45.50% | 47.83% | 45.08% | 42.73% | 42.06% |
Profit Margin | 35.35% | 33.14% | 34.77% | 36.03% | 31.38% | 33.92% |
Free Cash Flow Margin | 23.02% | 19.08% | 25.41% | 35.78% | 37.72% | 34.56% |
EBITDA | 173,677 | 153,295 | 145,691 | 110,736 | 81,119 | 63,770 |
EBITDA Margin | 52.72% | 49.60% | 50.17% | 47.68% | 45.84% | 45.29% |
D&A For EBITDA | 12,292 | 12,677 | 6,790 | 6,038 | 5,501 | 4,553 |
EBIT | 161,385 | 140,618 | 138,901 | 104,698 | 75,618 | 59,217 |
EBIT Margin | 48.99% | 45.50% | 47.83% | 45.08% | 42.73% | 42.06% |
Effective Tax Rate | 21.72% | 21.53% | 20.60% | 20.05% | 19.60% | 19.17% |